4.3 Article

Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?

期刊

JOURNAL OF CLINICAL NEUROSCIENCE
卷 16, 期 6, 页码 854-855

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2008.09.005

关键词

Temozolomide; Glioma; Glioblastoma multiforme

向作者/读者索取更多资源

Temozolomide (TMZ) is an alkylating agent used in the management of gliomas. Although TMZ is generally safe and acute toxicity is well documented, there are limited data on long-term toxicities. We present three patients with glioma; all patients started on TMZ after having progressed following primary treatment. These patients have continued TMZ for 5 years, 7 years and 8 years respectively. So far they have had no serious side effects. We discuss these patients while raising the question of prolonged TMZ use. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据